Key Market Indicators
Slovak Antidepressant Medicine Sales are projected to reach approximately $21 million by 2028, up from around $20 million in 2023, marking an average annual growth rate of 0.3%. Since 2001, the Slovak market has seen a yearly increase of 1.1%. In the rankings for 2023, Slovakia held the 12th position, just surpassed by Hungary, which also posted sales of around $20 million. Leading the global market, Spain, Italy, and Australia secured the second, third, and fourth spots, respectively.
